Johnson & Johnson (JNJ) Social Stream
JOHNSON & JOHNSON (JNJ) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering JNJ.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-21 | 10 | $215 | $175 | $191.111 | $156.88 | 21.82% |
| 2021-12-15 | 10 | $215 | $175 | $190.555 | $156.88 | 21.47% |
| 2022-01-26 | 9 | $215 | $175 | $189.222 | $156.88 | 20.62% |
| 2022-01-27 | 9 | $215 | $175 | $190 | $156.88 | 21.11% |
| 2022-03-07 | 10 | $215 | $175 | $189.444 | $156.88 | 20.76% |
| 2022-04-04 | 11 | $215 | $175 | $188.8 | $156.88 | 20.35% |
| 2022-04-14 | 11 | $215 | $173 | $188.6 | $156.88 | 20.22% |
| 2022-04-20 | 11 | $215 | $173 | $189.6 | $156.88 | 20.86% |
| 2022-04-21 | 11 | $215 | $173 | $191.2 | $156.88 | 21.88% |
| 2022-05-20 | 12 | $215 | $173 | $190.272 | $156.88 | 21.29% |
| 2022-06-06 | 12 | $215 | $173 | $189.818 | $156.88 | 21% |
| 2022-09-07 | 16 | $215 | $165 | $186.333 | $156.88 | 18.77% |
| 2022-09-17 | 16 | $215 | $165 | $186.266 | $156.88 | 18.73% |
| 2022-10-05 | 15 | $215 | $165 | $186.066 | $156.88 | 18.6% |
| 2022-10-12 | 16 | $215 | $165 | $186.066 | $156.88 | 18.6% |
| 2022-10-13 | 16 | $215 | $165 | $186.133 | $156.88 | 18.65% |
| 2022-10-14 | 16 | $215 | $165 | $185.666 | $156.88 | 18.35% |
| 2022-10-19 | 17 | $215 | $165 | $185.4 | $156.88 | 18.18% |
| 2022-10-20 | 17 | $215 | $160.001 | $184 | $156.88 | 17.29% |
| 2022-11-28 | 17 | $215 | $160 | $184.437 | $156.88 | 17.57% |
| 2022-12-01 | 16 | $215 | $160 | $185.6 | $156.88 | 18.31% |
| 2022-12-12 | 17 | $215 | $160 | $185.25 | $156.88 | 18.08% |
| 2023-01-20 | 17 | $215 | $160 | $185.687 | $156.88 | 18.36% |
| 2023-01-25 | 17 | $215 | $160 | $185.187 | $156.88 | 18.04% |
| 2023-02-21 | 17 | $215 | $168 | $185.937 | $156.88 | 18.52% |
| 2023-03-01 | 18 | $215 | $161 | $184.47 | $156.88 | 17.59% |
| 2023-03-31 | 18 | $215 | $161 | $183.588 | $156.88 | 17.02% |
| 2023-04-11 | 18 | $215 | $161 | $183.529 | $156.88 | 16.99% |
| 2023-04-12 | 18 | $215 | $161 | $183.687 | $156.88 | 17.09% |
| 2023-04-19 | 17 | $215 | $161 | $183.687 | $156.88 | 17.09% |
| 2023-04-21 | 17 | $215 | $161 | $183.312 | $156.88 | 16.85% |
| 2023-06-06 | 17 | $215 | $161 | $182.062 | $156.88 | 16.05% |
| 2023-06-14 | 18 | $215 | $161 | $182.062 | $156.88 | 16.05% |
| 2023-07-11 | 17 | $215 | $161 | $182.2 | $156.88 | 16.14% |
| 2023-07-13 | 17 | $215 | $161 | $181.571 | $156.88 | 15.74% |
| 2023-07-18 | 16 | $215 | $161 | $181.571 | $156.88 | 15.74% |
| 2023-07-21 | 16 | $215 | $161 | $182.461 | $156.88 | 16.31% |
| 2023-07-31 | 15 | $215 | $161 | $183.384 | $156.88 | 16.89% |
| 2023-08-30 | 15 | $215 | $161 | $183.615 | $156.88 | 17.04% |
| 2023-08-31 | 16 | $215 | $161 | $182.357 | $156.88 | 16.24% |
| 2023-09-06 | 16 | $215 | $161 | $181.866 | $156.88 | 15.93% |
| 2023-09-08 | 16 | $215 | $158 | $180.4 | $156.88 | 14.99% |
| 2023-09-12 | 16 | $215 | $158 | $179.866 | $156.88 | 14.65% |
The Trend in the Analyst Price Target
JNJ's average price target has moved down $6.65 over the prior 14 months.
Over the past 49 weeks, JNJ's average upside potential has been 11.49%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-28 | 16 | 215 | 160 | 184.437 | 177.33 | 4.01% |
| 2022-12-12 | 17 | 215 | 160 | 185.250 | 177.84 | 4.17% |
| 2023-01-31 | 17 | 215 | 168 | 185.937 | 163.42 | 13.78% |
| 2023-04-17 | 17 | 215 | 161 | 183.687 | 165.67 | 10.88% |
| 2023-07-13 | 17 | 215 | 161 | 181.571 | 158.81 | 14.33% |
JNJ Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.06 | 7 | 1 | 8 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
JNJ's average broker recommendation rating worsened by 0.28 over the prior 22 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, JOHNSON & JOHNSON's average analyst price target is higher than 4926.28% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, JOHNSON & JOHNSON's number of analysts covering the stock is higher than 4864.77% of them.
- In the context of Pharmaceutical Products stocks, JOHNSON & JOHNSON's variance in analysts' estimates is lower than -699.13% of them.
- In terms of how JOHNSON & JOHNSON fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 881.1% of that group.
In the Pharmaceutical Products industry, PFE, LLY, and ABT are the three stocks most similar to JOHNSON & JOHNSON regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding JNJ using the data that counts. Try POWR Ratings for free.